A look at what's coming to Contemporary OB/GYN® this week.
Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.
The latest trial results showed statistically significant improvements in overall survival and progression-free survival.
Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla®) transdermal system.
Check back soon for additional updates.
A legacy of excellence: Reflecting on the final print edition of Contemporary OB/GYN
April 25th 2025Marking the end of an era and the beginning of a new chapter, the final print edition of Contemporary OB/GYN celebrates over 50 years of evidence-based guidance and unwavering support for clinicians.
Read More